Our pilot study on the expression levels of YB-1 and DbpA in clear cell renal cell carcinomas (ccRCC) performed by immunohistochemistry demonstrates that (i) both proteins are mostly upregulated concordantly in tumor cells. The gene discussed is YBX3; the disease is nonpapillary renal cell carcinoma.